zonisamide and its Impurities
Zonisamide is used to treat the symptoms of epilepsy and Parkinson's disease. It is a sulfonamide anticonvulsant. Zonisamide may be a carbonic anhydrase inhibitor although this is not one of the primary mechanisms of action.Reference standards of Zonisamide API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
 
	
			                                   
																				Zonisamide Related Compound C (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide) (1725036)
Zonisamide Related Compound C (N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide) (1725036)
- Catalogue No.:PA USP1725036 
- CAS : - NA
- Molecular Formula : NA 
- Molecular Weight : NA 

 
																				 
																				![Benzo[d]isoxazol-3-yl-methanesulfonyl chloride PA 26 08520](https://www.pharmaffiliates.com/pimages/PA2608520.jpg) 
																				 
																				 
																				 
																				 
																				 
																				![Benzo[d]isoxazol-3-ylmethanesulfonic Acid PA 26 08580](https://www.pharmaffiliates.com/pimages/PA2608580.jpg) 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				 
																				![N-(Benzo[d]isoxazol-3-yl)-N-methylmethanesulfonami PA 26 0081001](https://www.pharmaffiliates.com/pimages/PA260081001.jpg) 
																				 
																				 
 
 
 
